1. Home
  2. ATAI vs KGEI Comparison

ATAI vs KGEI Comparison

Compare ATAI & KGEI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATAI
  • KGEI
  • Stock Information
  • Founded
  • ATAI 2018
  • KGEI 2008
  • Country
  • ATAI Germany
  • KGEI United States
  • Employees
  • ATAI N/A
  • KGEI N/A
  • Industry
  • ATAI Biotechnology: Pharmaceutical Preparations
  • KGEI
  • Sector
  • ATAI Health Care
  • KGEI
  • Exchange
  • ATAI Nasdaq
  • KGEI Nasdaq
  • Market Cap
  • ATAI 271.6M
  • KGEI 262.6M
  • IPO Year
  • ATAI 2021
  • KGEI N/A
  • Fundamental
  • Price
  • ATAI $1.48
  • KGEI $7.87
  • Analyst Decision
  • ATAI Strong Buy
  • KGEI Strong Buy
  • Analyst Count
  • ATAI 4
  • KGEI 1
  • Target Price
  • ATAI $9.00
  • KGEI $11.00
  • AVG Volume (30 Days)
  • ATAI 1.8M
  • KGEI 156.6K
  • Earning Date
  • ATAI 03-17-2025
  • KGEI 05-12-2025
  • Dividend Yield
  • ATAI N/A
  • KGEI N/A
  • EPS Growth
  • ATAI N/A
  • KGEI 2.07
  • EPS
  • ATAI N/A
  • KGEI 0.51
  • Revenue
  • ATAI $308,000.00
  • KGEI $58,651,000.00
  • Revenue This Year
  • ATAI N/A
  • KGEI $17.58
  • Revenue Next Year
  • ATAI $20.00
  • KGEI $37.44
  • P/E Ratio
  • ATAI N/A
  • KGEI $15.33
  • Revenue Growth
  • ATAI N/A
  • KGEI 16.56
  • 52 Week Low
  • ATAI $0.78
  • KGEI $2.85
  • 52 Week High
  • ATAI $2.85
  • KGEI $9.89
  • Technical
  • Relative Strength Index (RSI)
  • ATAI 47.88
  • KGEI 52.88
  • Support Level
  • ATAI $1.37
  • KGEI $7.06
  • Resistance Level
  • ATAI $1.66
  • KGEI $8.36
  • Average True Range (ATR)
  • ATAI 0.11
  • KGEI 0.53
  • MACD
  • ATAI 0.02
  • KGEI -0.04
  • Stochastic Oscillator
  • ATAI 65.22
  • KGEI 72.63

About ATAI ATAI Life Sciences N.V.

ATAI Life Sciences NV is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. Its product candidates include COMP360/Psilocybin therapy, PCN-101/R-ketamine, RL-007/Compound, DMX-1002/Ibogaine, GRX-917/Deuterated etifoxine, VLS-01/DMT, EMP-01/MDMA derivative, RLS-01/Salvinorin A, KUR-101/Deuterated Mitragynine, and DMX-1001/Noribogaine. The business operates geographically in two regions being the United States and Germany.

About KGEI Kolibri Global Energy Inc. Common stock

Kolibri Global Energy Inc is a North American energy company focused on finding and exploiting energy projects in oil, gas, and clean and sustainable energy. It is focused on the acquisition, exploration, and production of oil and gas reserves. The company owns and operates shale oil and gas properties in the United States. Its segments include the United States, Canada and Others. The company derives a majority of its revenue from the United States.

Share on Social Networks: